 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
1 |
Broad, A, Campano, LM, Davis, ID, Rosenthal, M and Toner, G A phase II trial of anti-idiotypic p53 peptides (Pentrys) in patients with hormone-refractory prostate cancer. Asia Pacific Journal of Clinical Oncology 3: 1-8.. 1-8: (2007) |
2 |
Barlow, J., Cebon, J., Davis, I.D., Frederiksen, K.S., Lundsgaard, D., McArthur, G.A., Moller, N.P.H., Nicholaou, T., Skak, K., Skrumsager, B.K. and Thygesen, P. Recombinant human interleukin-21 (rIL-21): an open-label, two arm, phase 1 trial in patients with metastatic melanoma. Clinical Cancer Research. In press.: (2007) |
3 |
Baka, S., Beith, J., Davis, I., Harris, P., Haydon, A., Hersey, P., Kefford, R., Margison, G.P., McArthur, G.A., Middleton, M.R., Mortimer, P., Ranson, M., Sabharwal, A., Seebaran, A., Thompson, D. and Watson, A.J. A randomised trial of the combination of lomeguatrib and temozolomide and temozolomide alone in patients with advanced melanoma. Journal of Clinical Oncology. In press.: (2007) |
4 |
Lim, E. and Rosenthal, M.A. Diagnosing cancer: changing patterns of care. Internal Medicine Journal. 37: 124-6 (2007) |
5 |
Grigg, A.P., Ritchie, D.S., Roberts, A.W., Seymour, J.F., et. al. The hyper-CVAD-rituximab chemotherapy program followed by high-dose busulphan, melphalan and autologous stem cell transplantation produces excellent event free survival in patients with previously untreated mantle cell lymphoma. Ann Hematol. In press.: (2006) |
6 |
Grigg, A.P. The effect of hydroxyurea on sperm count, motility and morphology in adult males with sickle cell or myeloproliferative disease. Int Med J. In press.: (2006) |
7 |
D'Souza, A.B., Ebeling, P.R., Grigg, A.P. and Szer, J. Zoledronic acid prevents bone loss after allogeneic hemopoietic stem cell transplantation. Int Med J. 36: 600-3 (2006) |
8 |
Grigg, A.P. and Hughes, T. The role of allogeneic stem cell transplantation for adult chronic myeloid leukaemia in the imatinib era. Biol Blood Marrow Transplant. 12: 795-807 (2006) |
9 |
Bardy, P., Diviney, M., Grigg, A.P., Murphy, N., Szer, J., et. al. Donor methylenetetrahydrofolate reductase genotype is associated with graft versus host disease in hematopoietic stem cell transplant patients treated with methotrexate. Bone Marrow Transplant. 37: 773-779 (2006) |
10 |
Ganju, V. and Grigg, A.P. PET positive progressive transformation of germinal centres masquerading as relapsed Hodgkin lymphoma post autograft. Leukaemia and Lymphoma. 47: 764-65 (2006) |